Top Markets
#1 Fabric Protocol Fabric Protocol +29.17%
#2 The Black Bull The Black Bull +28.64%
#3 Ethena Staked ENA Ethena Staked ENA +28.15%
#4 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +27.44%
#5 Bitcoin Cash Bitcoin Cash +26.84%
#6 HashKey Platform Token HashKey Platform Token +26.07%
#7 GALA GALA +25.71%
#8 Zora Zora +24.31%
#9 Pieverse Pieverse +23.14%
#10 Prom Prom +23.08%
Coin of the day
Fabric Protocol Fabric Protocol
Innstillinger
Språk
NORSK
Valuta
USD
Tema
ERYTECH Pharma S.A. ERYTECH Pharma S.A.

ERYTECH Pharma S.A.

ERYP
Rangering i aksjer #24698
ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on... ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on creating innovative therapies derived from red blood cells. These treatments target various types of cancer and rare (orphan) diseases, with the company operating in both France and the United States. Its primary experimental drug, eryaspase, is currently undergoing Phase 3 clinical trials for patients battling second-line pancreatic cancer. Furthermore, this candidate is also in Phase 2 development for triple-negative breast cancer and for individuals with second-line acute lymphoblastic leukemia. The company is additionally advancing erymethionase, a preclinical-stage product. This candidate utilizes methionine-gamma-lyase, encased within red blood cells, to specifically address cancers that are dependent on methionine for growth. Established in 2004, ERYTECH Pharma's corporate headquarters are situated in Lyon, France.
Aksjekurs
$0.95011029
Sist synkronisert: 2023-06-28
Markedsverdi
$57.72M
Endring (1 dag)
8.53%
Endring (1 år)
0.00%
Land
FR
Handel ERYTECH Pharma S.A. (ERYP)

Kategori

Healthcare
Inntekter for ERYTECH Pharma S.A. (ERYP)
Inntekter i 2026 TTM: 0
Ifølge ERYTECH Pharma S.A. sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for ERYTECH Pharma S.A. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH